Discontinuation of mycophenolate mofetil from a tacrolimus-based triple regimen 2 months after renal transplantation: a comparative randomized multicentre study

Abstract

This study investigated the early discontinuation of mycophenolate mofetil (MMF) from a standard triple regimen. Patients were randomized either to receive a continued tacrolimus/MMF/steroids triple regimen (control group) or to reduce and then stop the MMF dose (MMF stop group).

Both groups received identical daily tacrolimus and corticosteroid doses.

Keywords

• Discontinuation
• mycophenolate
• mofetil
• tacrolimus-based
• triple
• regimen
• months
• after
• renal
• transplantation
• comparative
• randomized
• multicentre
• study